Recognition and prevention of nosocomial invasive fungal infections in the intensive care unit

Critical Care Medicine
Jeannina A Smith, Carol A Kauffman

Abstract

Despite recent advances in antifungal treatments, the morbidity and mortality of fungal infections, especially invasive candidiasis, in patients in the intensive care unit setting remain high. Because of this, there has been a great interest in improving the evaluation, risk assessment, and prevention of fungal infections in the intensive care unit. Some important advances in the diagnosis of invasive candidiasis include rapid species identification and improvements in antigen testing. The introduction of several prediction rules has helped to guide clinicians in the use of prophylaxis or preemptive antifungal therapy in high-risk patients. However, the most immediate benefit has been realized with the introduction of new antifungal agents that have proved to be safer than those available in the past.

References

Sep 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·V J FraserW C Dunagan
Mar 1, 1990·Journal of Clinical Microbiology·P MuñozE Bouza
May 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M A Pfaller
May 21, 1998·Ophthalmology·S P Donahue
Jun 15, 1999·Archives of Surgery·A P Borzotta, K Beardsley
Jan 9, 2001·Diagnostic Microbiology and Infectious Disease·J LoefflerH Einsele
Feb 15, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J H RexJ E Edwards
Apr 3, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J H Rex, J D Sobel
Jun 22, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·H M BlumbergUNKNOWN National Epidemiology of Mycoses Survey(NEMIS) Study Group
Mar 15, 2002·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Denise GravelGary Garber
Mar 22, 2002·Intensive Care Medicine·Corinne AlbertiRoger Le Gall
Nov 13, 2002·The American Journal of Medicine·Stijn I BlotFrancis A Colardyn
Aug 28, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter G PappasUNKNOWN NIAID Mycoses Study Group
Oct 15, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Olafur GudlaugssonDaniel Diekema
Nov 1, 2003·The Lancet Infectious Diseases·Philippe EggimannDidier Pittet
Nov 19, 2003·Current Opinion in Infectious Diseases·Luis Ostrosky-Zeichner
Dec 4, 2003·The Lancet Infectious Diseases·Philippe EggimannDidier Pittet
Mar 17, 2004·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·P M OlaecheaUNKNOWN EPCAN Study Group
Mar 31, 2004·Transplantation Proceedings·G GuaraldiA D Pinna
Aug 13, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Hilmar WisplinghoffMichael B Edmond
Sep 11, 2004·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Laura PuzniakLouis Polish
Jul 16, 2005·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Juliette MorganSteven M Teutsch
Aug 5, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Luis Ostrosky-ZeichnerJohn H Rex
Aug 19, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Carol A Kauffman
Sep 6, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Anurag MalaniCarol A Kauffman
Sep 9, 2005·Critical Care Medicine·Andrew F ShorrMarin H Kollef
Oct 6, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Theoklis E ZaoutisChris Feudtner
Apr 22, 2006·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Mario CrucianiPaolo Grossi
Jun 8, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kevin W GareyDavid T Bearden

❮ Previous
Next ❯

Citations

May 9, 2012·Folia Microbiologica·Lenka Bašková, Vladimír Buchta
Apr 2, 2014·Annales Françaises D'anesthèsie Et De Rèanimation·P MassanetP Corne
Sep 20, 2011·International Journal of Antimicrobial Agents·Mahipal SinnollareddyJason A Roberts
Apr 20, 2016·Critical Reviews in Biotechnology·Mohammadali SafaviehWaseem Asghar
Aug 24, 2011·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Kely RelyGuillermo Salinas Escudero
Sep 28, 2013·Acta Medica (Hradec Králové)·Mohammad T HedayatiMohammad R Habibi
Aug 5, 2010·Critical Care Medicine·Jan E PattersonLisa L Maragakis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.